Portage Biotech Inc. (PRTG)
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders